India grants first compulsory license to generic drug producer
Submitted by susan on Thu, 2012-03-15 12:04
In a landmark move, the Indian Patent Office announced on Monday that it has issued its first compulsory license to a domestic generic drug-maker. The decision effectively ends German pharmaceutical company Bayer AG's monopoly over an anti-cancer drug and authorises the production of a low-cost version for the Indian market.
Main Topic:
Attachment(s):
Mark Content Private(Internal):
External URL:
http://ictsd.org/i/news/bridgesweekly/128236/
Email Alert:
10
16
Publication Date:
14/03/2012